Down-regulated RINGl and YYl binding protein (RYBP) is reported to be an independent predictor of a poor prognosis in patients with hepatocellular carcinoma (HCC). However, the genetic association of RYBP polymorphisms with HCC risk and prognosis has not been investigated now. In this study, five RYBP SNPs, rs12956, rs2118593, rs17009699, rs4676875 and rs4532099, were studied from a hospital-based case-control study including 1100 cases (HCC patients) and 1100 controls (non-HCC patients) in Guangxi, China. All these SNPs interacted with environmental risk factors, such as HBV infection, alcohol intake and smoking in the pathogenesis of HCC. Compared to the CC genotype, patients with TT genotype of rs12956 had a decreased risk of HCC (OR = 0.587, 95% CI = 0.403~0.923) and an increased survival time (Co-dominant, HR = 0.745, 95% CI = 0.594~0.934), while those with TT genotype of rs2118593 had an increased risk of HCC (OR = 1.538, 95% CI = 1.093~2.735) and a decreased survival time (Co-dominant, HR = 1.447, 95% CI = 1.174~1.782). No significant difference was found between the other three RYBP polymorphisms with HCC risk and prognosis. Furthermore, we found that tumor number, tumor staging, metastasis and rs2118593 were associated with the overall survival of HCC patients by multivariate COX regression analysis. Our study suggests RYBP SNP, rs2118593 as a new predictor for poor prognosis of HCC patients.
Introduction
Hepatocellular carcinoma (HCC) is a common malignant tumor of digestive system, results from the interaction between environmental and genetic factors (1, 2) . There are about 800 000 new HCC cases worldwide each year, of which more than 50% occurs in China (3, 4) . As one area with the highest incidence of HCC in China, HCC in Guangxi accounts for 40% of the whole tumor mortality and locates at the first place of cancer death spectrum. Epidemiological studies found that chronic HBV infection, alcohol intake, aflatoxin contaminated water, family history and unhealthy eating habits were all risk factors of HCC (5) (6) (7) . Chronic HBV infection has been confirmed to be one of the important causes of HCC. However, even in the high incidence area of HCC, there is only a small part of HBV infected people eventually develop to be HCC patients, and there is also a great difference of age among these HCC patients. This phenomenon suggests that different individuals have different responses to HBV infection and different genetic susceptibility to HCC. Because different populations or individuals have different susceptibility to carcinogens, the results of cancer development are not the same (8) .
Single nucleotide polymorphism (SNP) is a kind of congenital mutation with a more than 1% of population frequency, exists widely in human genome and is the most common genetic variation in humans (9) . In addition, SNP distributes widely over DNA as a biomarker, and reflects the genetic differences among races, populations and individuals better than other genetic markers (10, 11) . SNP has been implicated in the assessment of risk (12, 13) , early diagnosis (14) , prevention (15) , treatment of diseases (16) and drug development (17, 18) . Because of its important function and application value, SNP is a new comprehensive way to reduce incidence and improve prognosis of cancer, and a new hot-spot of study after the human genome project in recent years (19) .
In 1999, Emiliano Garcia found a new protein named RYBP (RINGl and YYl binding protein) in the study of polycomb group (PcG) protein (20) . As a component of PcG protein complex, RYBP inhibits gene transcription, regulates embryonic development and plays a role in epigenetic regulation (21) (22) (23) . RYBP was reported to be associated with the development of chronic sinusitis (24) , cervical cancer, prostate cancer and lung cancer (25) (26) (27) . RYBP gene deletion was found in prostate cancer patients and associated with TMPRSS2-ERG gene fusion, which had a detection rate higher than 50% in prostate cancer, and correlated with high recurrence rate and invasiveness of prostate cancer (25, 28) . Recent study showed that decreased RYBP expression may be closely related to the occurrence and development of HCC (29) . We also identified a correlation between RYBP expression and metastasis of HCC in our recent work (30) . However, the relationship between RYBP polymorphisms and HCC has not yet been reported.
In order to clarify the roles of RYBP polymorphisms play in HCC, this study conducted genotyping of RYBP candidate SNPs to investigate the relationship between RYBP SNPs and HCC. Moreover, we analyzed the correlation between RYBP SNPs and clinicopathological characteristics of HCC patients to provide reference information for the clinical prognosis evaluation.
Materials and methods

Ethics Statement
This study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, and all of the patients provided written informed consent. All the methods were carried out in accordance with the approved guidelines.
Study population
The case group consisted of 1100 new cases of HCC patients who were recruited after a radiologic and pathologic diagnosis of HCC from department of hepatobiliary surgery, the First Affiliated Hospital of Guangxi Medical University from June 2007 to March 2015. All patients did not receive any chemotherapy or radiotherapy before sample collection. The control group consisted of 1100 cases of non-HCC patients who were selected from department of ophthalmology, spinal bone marrow surgery and trauma hand surgery, the First Affiliated Hospital of Guangxi Medical University at the same time. The control group was frequency matched with the case group according to gender, age and nation.
Investigation and sample collection
The questionnaire used in the investigation was designed after consulting experts, and included basic information of study population, epidemiological information (past history, personal history, family history, smoking and drinking history) and clinical information [tumor size, number, staging, cirrhosis, portal vein tumor thrombus (PVTT), hepatitis virus infection, AFP level, histological grade, vascular invasion, resection margin, lymph node metastasis and distant metastasis]. The investigation was conducted by professional investigators in a face-to-face way. Two milliliters of peripheral blood sample was collected from each participant the second day after they were hospitalized. Blood DNA was extracted by phenol-chloroform and stored at −80°C.
Follow-up study
Four hundred and sixty one HCC patients who received surgical resection between July 2010 and March 2015 were followed-up by telephone or out-patient recheck. The follow-up was conducted once every six months since the inception date until June 2015. The survival time was calculated monthly from the first day after operation to the day that patients had metastasis, recurrence, death or the end of the followup. At the end of follow-up, the follow-up rate was 92.19%, in which 36 patients were lost to follow-up and 425 patients had complete follow-up data.
The inclusion criteria for study population in follow-up: (i) preoperative blood and imaging examination showed they could undergo radical surgery; (ii) they were confirmed as HCC patients by clinic-pathologic detection after radical surgery; (iii) provided the required blood sample; (iv) had complete clinical and prognosis information; (v) signed the informed consent. The exclusion criteria: (i) didn't undergo radical surgery; (ii) had no complete clinical information; (iii) refused to provide blood sample; (iv) refused to sign the informed consent.
SNPs screening and genotyping
High frequency mutations in Chinese population that minimum allele frequency (MAF) was more than 0.05 were screened as candidate RYBP SNPs in database of national institute of environmental health sciences (NIEHS). Combined with related references, five RYBP SNPs were chosen, rs4676875, rs12956, rs17009699, rs2118593 and rs4532099.
TaqMan MGB high-throughput RT-PCR method on Applied Biosystems 7500 Fast Real-Time PCR System (ABI, USA) was used for SNP genotyping with TaqMan SNP Genotyping Assays kit according to the manufacturer's instructions. The genomic DNA was amplified at 95°C for 10 min, followed by 50 cycles of 95°C for 15 s and 60°C for 60 s. The results were analyzed using 7500 Fast System V1.4.0 SDS software. For quality control, 5% sample DNA was chosen to repeat the genotyping and the concordance rate was 100%. The genotyping was repeated once again when the sample couldn't be genotyped, and the sample was abandoned if it could not be genotyped in the repeat genotyping. SPSS 19 .0 software was used for statistical analysis. Hardy Weinberg equilibrium (HWE) test in the control group was performed using Haploview 4.2. Qualitative and quantitative data were analyzed by χ 2 and t-test, respectively. SNP-SNP interaction, gene-environment interaction, 95% confidence interval (CI) and odds ratio (OR) were analyzed by binary Logistic regression model. The median survival time (MST) was calculated from the date of diagnosis to the date of death or the end of follow-up (June 2015). The overall survival curves were draw by Kaplan-Meier method and the differences between groups were analyzed using Log-rank test. Single factor and multivariate COX regression were used for calculating hazardratio (HR) and 95% CI. All tests were two-tailed and P < 0.05 was considered statistically significant.
Statistical analysis
Results
General characteristics of cases and controls
The general characteristics of cases and controls are shown in Supplementary Table 1 . The gender, age and nation of patients in two groups were not statistically different (P > 0.05). However, significant differences were observed between cases and controls regarding alcohol intake, smoking, HBV infection and family history of HCC (P < 0.001). 
Abbreviations
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Associations of RYBP polymorphisms with HCC risk
As shown in Table 1 , after multivariate Logistic regression analysis, two RYBP SNPs, rs12956 and rs2118593 had significant difference between cases and controls (P < 0.05). Moreover, HCC patients with the genotype TT of rs12956 had a decreased risk of HCC, but those with the genotype TT of rs2118593 had an increased risk of HCC. No statistically significant differences were observed in the genotype distribution of the other three RYBP SNPs, rs17009699, rs4676875 and rs4532099, between cases and controls (P > 0.05).
Gene-environment interaction
Logistic regression analysis showed that the five RYBP SNPs, rs12956, rs2118593, rs17009699, rs4676875 and rs4532099, had interactions with HBV infection, alcohol intake and smoking in the pathogenesis of HCC (P < 0.05, Supplementary Table 3) .
SNP-SNP interaction
Binary Logistic regression analysis found that there were interactions between rs12956 and rs2118593, rs12956 and rs4532099, rs2118593 and rs4676875, rs2118593 and rs4532099, respectively. Furthermore, all these SNP-SNP interactions increased the risk of HCC (Supplementary Table 4 ).
Associations between RYBP polymorphisms and clinical characteristics of HCC patients
The associations between RYBP polymorphisms and clinical characteristics of HCC patients are shown in Table 2 . RYBP SNP rs12956 was associated with tumor number, AFP level and lymph node metastasis, and rs2118593 was correlated with tumor staging and lymph node metastasis. While the other three RYBP SNPs, rs17009699, rs4676875 and rs4532099 had no correlation with tumor size, tumor number, tumor staging, AFP level or lymph node metastasis.
Associations between general demographic and clinical characteristics with the prognosis of HCC patients
At the end of the follow-up, there were 158 of 425 HCC cases died, accounting for 37.2%. As shown in Table 3 , the prognosis of HCC patients was associated with these clinical characteristics, tumor size, tumor number, tumor staging, AFP level and lymph node metastasis (P < 0.05), while had no association with these general demographic characteristics, age, gender, family history and HBV infection (P > 0.05).
The effect of RYBP genotype distribution on the prognosis of HCC patients
The co-dominant and dominant models of RYBP SNPs, rs12956 and rs2118593, had a significant effect on the prognosis of HCC patients ( Figure 1A and 1B, Supplementary Figure 1A and 1B, Table 4 ). Compared to the patients with genotype CC of rs12956, the survival time of patients with genotype CT, TT or CT/TT was significantly increased ( Figure 1A and Supplementary Figure 1A) . However, the survival time of patients with genotype CT, TT or CT/TT of rs2118593 was decreased than that of patients with CC genotype ( Figure 1B and Supplementary Figure 1B) . In addition, both rs12956 and rs2118593 recessive models had no effect on the survival time of HCC patients. The genotype distribution of the other three RYBP SNPs, rs17009699, rs4676875 and rs4532099, had no effect on the survival time of HCC patients (Table 4 , Figure 1C -E, Supplementary Figure 1C- 
Regression model analysis on the overall survival of HCC patients
The variables that had influence on the prognosis of HCC patients, such as RYBP polymorphisms: rs12956 and rs2118593, and clinical characteristics: tumor size, tumor number, tumor staging, AFP level and lymph node metastasis, were included in the multivariate COX regression analysis according to the inclusion criteria for 0.05 and the exclusion criteria for 0.10. As shown in Table 5 , tumor number, tumor staging, metastasis and rs2118593 were associated with the overall survival of HCC patients.
Discussion
HCC is a genetic disease that results from the interaction between multiple genes and environmental factors (1) (2) (3) . That is to say, the genetic factors determine the majority of HCC susceptibility (31) , and the environmental factors are the cause to promote the pathogenesis of HCC (32) . Accumulated evidences have showed that genetic variation, HBV infection, heavy drinking and smoking are risk factors of HCC (33, 34) . In this study, we conducted an analysis of RYBP polymorphisms and found that rs12956 was a protective SNP in the pathogenesis of HCC, Figure 1 . The effect of RYBP polymorphisms on the prognosis of HCC patients. Kaplan-Meier overall survival curves for HCC patients based on co-dominate genotypes of (A) rs12956, (B) rs2118593, (C) rs4532099, (D) rs4676875 and (E) rs17009699. P value is from the log-rank test.
and rs2118593 increased the risk of HCC, while genotype distribution of rs17009699, rs4676875 and rs4532099 had no statistically significant differences between the case and control group. In addition, the five RYBP SNPs, rs12956, rs2118593, rs17009699, rs4676875 and rs4532099, interacted with such environment factors, HBV infection, alcohol intake and smoking by binary Logistic regression analysis. SNP-SNP interaction showed that there were interactions between rs12956 and rs2118593, rs12956 and rs4532099, rs2118593 and rs4676875, rs2118593 and rs4532099, and the interactions can increase the risk of HCC.
These results indicate that the interaction between RYBP polymorphisms and environmental risk factors plays an important role in the development of HCC, suggesting a new way to the prevention and treatment of HCC by combining the gene polymorphisms with environmental risk factors. HCC is a highly malignant tumor with very poor prognosis (35, 36) , and the five-year survival rate of HCC patients is less than 30% (37) . The prognosis of tumor patients is closely related with clinical pathological characteristics of patients. Studies have showed that the prognosis of HCC was correlated with tumor size, tumor number, tumor staging, AFP level and lymph node metastasis (38, 39) . Gene polymorphisms play a very important role in tumor occurrence and development. Because of the presence of gene polymorphisms, mutations in key area of gene may induce tumorigenesis, and HCC patients may have different clinical and pathological features. In consistent with these studies, we found that RYBP SNP, rs12956 was associated with tumor number, AFP level and lymph node metastasis of HCC patients, and rs2118593 was associated with tumor staging and lymph node metastasis. This may be the basis of the association between rs12956 and rs2118593 with HCC prognosis. However, there was no correlation between rs17009699, rs4676875 and rs4532099 with tumor size, tumor number, tumor staging, AFP level or lymph node metastasis. Previous study reported that decreased expression of RYBP promoted the invasion and metastasis of HCC and was associated with the prognosis of HCC patients (29) . In accordance with previous study, RYBP SNPs, rs12956 and rs2118593, also had a significant effect on the prognosis of HCC patients, and rs12956 increased the survival time, while rs2118593 significantly decreased the survival time of patients in our study. Our results suggest that rs12956 may be a protective factor to improve HCC prognosis, and rs2118593 may be a risk factor indicating a poor prognosis of HCC. The multivariate COX regression analysis further supports that rs2118593 was associated with poor prognosis of HCC patients.
Function prediction of RYBP polymorphisms in NIEHS database show that rs12956 locates at a miRNA binding site, and rs2118593 is at a transcription factor binding site (TFBS), suggesting that both rs12956 and rs2118593 are functional RYBP SNPs and may cause differences of individual susceptibility to tumors by regulating the activity of RYBP and the downstream proteins (40) . The putative role of RYBP as a tumor suppressor gene is supported by the observations that RYBP is down-regulated in some tumors resulting in a poor prognosis, inhibits the proliferation and metastasis of tumor cells, and promotes the apoptosis (27, 29) . Therefore, rs12956 and rs2118593 may regulate RYBP expression by altering the binding ability to RYBP, resulting in patients of HCC with different genotypes presents different prognosis. This hypothesis needs further studies of RYBP expression profile in tumor tissues, which will also confirm the exact function of rs12956 and rs2118593 in the prognosis of HCC patients.
To our knowledge, this is the first study to show the correlation between RYBP polymorphisms with the risk and prognosis of HCC. We found that the RYBP SNP, rs2118593 can be a new predictor for poor prognosis of HCC, providing a scientific basis for improving the treatment and prognosis of HCC. However, the roles of RYBP SNPs playing in treatment and prevention of tumors need to increase the study population, nations, prospective and multiple tumor researches, and function experiments to further verify.
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